Articles written by Juan Spínelli - Benzinga

DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process

Researcher David Heldreth sues DEA over alleged legal violations in marijuana rescheduling, citing bias and exclusion of small businesses and Native American tribes.

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

Recent patents on novel psychedelic prodrugs show promise in enhancing stability and efficacy, offering new hope for effective mental health treatments.

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study

Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.

U.S. Election Stress Fuels Demand For Psychedelic-Assisted Therapy

Post-election stress has driven a surge in Americans seeking psychedelic therapy for relief, with clinics reporting record appointments.

Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031

Psychedelic mushrooms market to reach $3.3 billion by 2031, due to rising demand, regulatory changes & growing psilocybin acceptance.

Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing

Veterans seeking PTSD relief face legal challenges in accessing psychedelic therapies. Will these treatments become available to those in need?

UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis

A UK-funded study will explore psilocybin's potential to treat opioid addiction, with a focus on reducing high relapse rates.

California College Launches Nation's First Psychedelic Studies Degree For Undergraduates

CIIS launches the first undergraduate degree in psychedelic studies, training students to meet the demand for therapeutic expertise.

Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief

Pro golfers are using psychedelics like psilocybin and DMT to sharpen mental performance, signaling a new trend in sports wellness.

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health

Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.

Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?

Massachusetts voters have rejected Question 4, which sought to legalize and regulate certain psychedelics for therapeutic use.

Americans Favor Psilocybin For Mental Health Treatment, Study Finds

Most Americans support psilocybin use for mental health and well-being, a new study shows, marking a shift in attitudes toward psychedelics.

2024 Election Spotlight: Massachusetts And Oregon Tackle Psychedelics Reform

MA and OR voters decide on groundbreaking psychedelic policies in 2024, with measures that could redefine mental health treatment nationwide.

Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts

Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.

Cannabist Co. Joins Forces With 'Weed For Warriors' In Veterans Day Cannabis Donation Drive

Cannabist Company partners with Weed for Warriors to support veteran access to medical cannabis through a Veterans Day donation drive across 12 U.S. states.

JD Vance Considers Psychedelic Therapy For Vets: Insights From Joe Rogan Interview

JD Vance's discussed his views on therapeutic psychedelics for veterans, and his "live and let live" approach to drug policy.

EXCLUSIVE: Mike Tyson And Stündenglass Unveil The TYSON 2.0 Modül + Dok Travel Set

TYSON 2.0 Modül + Dok Deluxe Travel Set is a portable smoking device launched by Stündenglass and Mike Tyson to celebrate his fight with Jake Paul.

As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash

Compass Pathways delays key Phase 3 psilocybin trial readouts, triggering a 30% workforce reduction amid efforts to conserve cash and refocus.

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

Determining Who's 'Too High To Drive' Poses Challenge For Police Nationwide

Police face challenges in assessing cannabis impairment for drivers, relying on outdated methods without a reliable, standardized test.